Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LMYC anticorps (AA 186-439)

MYCL Reactivité: Souris WB, IHC, IP, IF/ICC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN2905308
  • Antigène Voir toutes LMYC (MYCL) Anticorps
    LMYC (MYCL) (Protein L-Myc (MYCL))
    Épitope
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 186-439
    Reactivité
    • 24
    • 9
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Souris
    Hôte
    • 29
    • 4
    Lapin
    Clonalité
    • 31
    • 2
    Polyclonal
    Conjugué
    • 24
    • 6
    • 2
    • 1
    Cet anticorp LMYC est non-conjugé
    Application
    • 27
    • 13
    • 10
    • 6
    • 5
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (fixed cells) (IF/ICC)
    Purification
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogène
    MYC (Ala186-Ala439)
    Top Product
    Discover our top product MYCL Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    500 μg/mL
    Buffer
    PBS,  pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4 °C for frequent use. Aliquot and store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
  • Antigène
    LMYC (MYCL) (Protein L-Myc (MYCL))
    Autre désignation
    V-Myc Myelocytomatosis Viral Oncogene Homolog (MYCL Produits)
    Synonymes
    anticorps MRTL, anticorps MYCC, anticorps bHLHe39, anticorps c-Myc, anticorps MYCL1, anticorps Lmyc1, anticorps Mycl1, anticorps LMYC, anticorps bHLHe38, anticorps CMYC, anticorps c-myc, anticorps ARC, anticorps B430311C09Rik, anticorps MYC, anticorps NOP, anticorps Nop30, anticorps RNCMYC, anticorps mMyc, anticorps C-MYC, anticorps AU016757, anticorps Myc2, anticorps Niard, anticorps Nird, anticorps AW536278, anticorps L-myc, anticorps Lmyc-1, anticorps l-myc, anticorps lmyc, anticorps lmyc-b, anticorps lmyc2, anticorps mycl1-b, anticorps xL-Myc2, anticorps fi04c04, anticorps mycl1b, anticorps si:ch211-194e15.2, anticorps wu:fa07c04, anticorps wu:fb19f03, anticorps wu:fi04c04, anticorps zgc:152988, anticorps lmyc1, anticorps mycl1, anticorps mycl1a, anticorps zgc:85967, anticorps lmyc-A, anticorps mycl, anticorps mycl1-a, anticorps xL-Myc1, anticorps xL-myc1, anticorps MYC proto-oncogene, bHLH transcription factor, anticorps v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog, anticorps MYCL proto-oncogene, bHLH transcription factor, anticorps nucleolar protein 3 (apoptosis repressor with CARD domain), anticorps myelocytomatosis oncogene, anticorps v-myc avian myelocytomatosis viral oncogene lung carcinoma derived, anticorps MYCL proto-oncogene, bHLH transcription factor S homeolog, anticorps MYCL proto-oncogene, bHLH transcription factor b, anticorps MYCL proto-oncogene, bHLH transcription factor a, anticorps MYCL proto-oncogene, bHLH transcription factor L homeolog, anticorps MYC, anticorps MYCL, anticorps Mycl, anticorps Nol3, anticorps Myc, anticorps mycl.S, anticorps myclb, anticorps mycla, anticorps mycl.L
    UniProt
    P01108
    Pathways
    L'effet Warburg
Vous êtes ici:
Support technique